Article
Alternative splicing and genetic variation of mhc-e: implications for rhesus cytomegalovirus-based vaccines.
Communications biology - 19 Dec 2022
Brochu Hayden, Wang Ruihan, Tollison Tammy, Pyo Chul-Woo, Thomas Alexander, Tseng Elizabeth, Law Lynn, Picker Louis J, Gale Michael, Geraghty Daniel E, Peng Xinxia
Abstract excerpt
Rhesus cytomegalovirus (RhCMV)-based vaccination against Simian Immunodeficiency virus (SIV) elicits MHC-E-restricted CD8+ T cells that stringently control SIV infection in ~55% of vaccinated rhesus macaques (RM). However, it is unclear how accurately the RM model reflects HLA-E immunobiology in humans. Using long-read sequencing, we identified 16 Mamu-E isoforms and all Mamu-E splicing junctions were detected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
